Variant report
Variant | nsv1000924 |
---|---|
Chromosome Location | chr3:84683816-84711713 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-VGLL3-6 | chr3:84687557-84688363 | ENSG00000242641.1 |
2 | lnc-VGLL3-6 | chr3:84693364-84693437 | NONHSAT090649 |
3 | lnc-VGLL3-6 | chr3:84687556-84688363 | NONHSAT090649 |
4 | lnc-VGLL3-6 | chr3:84693364-84693437 | ENSG00000242641.1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549925651 | chr3:84686407-84686408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs568744093 | chr3:84686459-84686460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576427488 | chr3:84686468-84686469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536162332 | chr3:84686576-84686577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370431887 | chr3:84686579-84686580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75060627 | chr3:84686588-84686589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73128878 | chr3:84686627-84686628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190038361 | chr3:84686642-84686643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539671422 | chr3:84686650-84686651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558604587 | chr3:84686663-84686664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376081886 | chr3:84686670-84686671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572047429 | chr3:84686679-84686680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559753783 | chr3:84686720-84686721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576879816 | chr3:84686729-84686730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146661457 | chr3:84686735-84686736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140216578 | chr3:84686768-84686769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145270385 | chr3:84686769-84686770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs116834218 | chr3:84686800-84686801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368442831 | chr3:84687556-84687557 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs115648256 | chr3:84687571-84687572 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs533459046 | chr3:84687608-84687609 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs551910034 | chr3:84687625-84687626 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs570141567 | chr3:84687660-84687661 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs537698548 | chr3:84687682-84687683 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs114110247 | chr3:84687684-84687685 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs375612001 | chr3:84687685-84687686 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs543207512 | chr3:84687742-84687743 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs368361113 | chr3:84687779-84687780 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs372585093 | chr3:84687783-84687784 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs185443606 | chr3:84687815-84687816 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs558077816 | chr3:84687825-84687826 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs576132417 | chr3:84687886-84687887 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs543674187 | chr3:84687968-84687969 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs368344932 | chr3:84687993-84687994 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs141879388 | chr3:84688008-84688009 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs150649641 | chr3:84688032-84688033 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs541389427 | chr3:84688038-84688039 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs188197422 | chr3:84688069-84688070 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs371920419 | chr3:84688084-84688085 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs528851596 | chr3:84688135-84688136 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs139156093 | chr3:84688167-84688168 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs901134 | chr3:84688173-84688174 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs371226106 | chr3:84688187-84688188 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs181347509 | chr3:84688200-84688201 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs118181065 | chr3:84688210-84688211 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs4373074 | chr3:84688248-84688249 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs78783360 | chr3:84688254-84688255 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs140146894 | chr3:84688286-84688287 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs150072095 | chr3:84688308-84688309 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs144326671 | chr3:84688331-84688332 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Medulloblastoma | 16783165 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:84686400-84686800 | Enhancers | H9 Cell Line | embryonic stem cell |
2 | chr3:84703000-84703200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr3:84703200-84711600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr3:84707000-84707800 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr3:84709000-84710000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr3:84709600-84710800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
7 | chr3:84710400-84710800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |